Global Aminoglycosides Antibiotics Market Growth 2023-2029
Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
LPI (LP Information)' newest research report, the “Aminoglycosides Antibiotics Industry Forecast” looks at past sales and reviews total world Aminoglycosides Antibiotics sales in 2022, providing a comprehensive analysis by region and market sector of projected Aminoglycosides Antibiotics sales for 2023 through 2029. With Aminoglycosides Antibiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aminoglycosides Antibiotics industry.
This Insight Report provides a comprehensive analysis of the global Aminoglycosides Antibiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aminoglycosides Antibiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Aminoglycosides Antibiotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aminoglycosides Antibiotics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aminoglycosides Antibiotics.
The global Aminoglycosides Antibiotics market size is projected to grow from US$ 1028.6 million in 2022 to US$ 1221.9 million in 2029; it is expected to grow at a CAGR of 1221.9 from 2023 to 2029.
The classification of Aminoglycosides Antibiotics includes Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin and Others. In addition, the proportion of Neomycin in 2019 is about 26%, and Etimicin mainly sales in China.
Aminoglycosides Antibiotics is widely used for Hospital, Clinic, Post Care Facility, Government & Military and Others. The most proportion of Aminoglycosides Antibiotics is for clinic, and the proportion in 2019 is about 35%.
Europe is the largest consumption place, with a consumption market share nearly 26% in 2019. Following Europe, China is the second largest consumption place with the consumption market share of about 16%.
Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma, Aike Pharmaceutical, Cipla, etc. are the leaders of the industry.
This report presents a comprehensive overview, market shares, and growth opportunities of Aminoglycosides Antibiotics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others
Segmentation by application
Hospital
Clinic
Post Care Facility
Government & Military
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Jemicare
Teva
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company
Key Questions Addressed in this Report
What is the 10-year outlook for the global Aminoglycosides Antibiotics market?
What factors are driving Aminoglycosides Antibiotics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aminoglycosides Antibiotics market opportunities vary by end market size?
How does Aminoglycosides Antibiotics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook